TLRY Tilray

Tilray Brands, Inc. to Announce First Quarter 2024 Financial Results on October 4, 2023

Tilray Brands, Inc. to Announce First Quarter 2024 Financial Results on October 4, 2023

NEW YORK and LEAMINGTON, Ontario, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its first quarter ended August 31, 2023 on October 4, 2023.

Live Audio Webcast

Tilray will host a live audio webcast to discuss these results at 8:30 am Eastern Time, which can be accessed on the Investors section of Tilray's website at . A replay will be available and archived on the Company’s website.

Retail Investor Q&A

Tilray Brands stockholders can submit and upvote questions via the stockholder Q&A platform Say Technologies beginning today and until October 3, 2023. To submit questions ahead of the webcast, please visit the Say Technologies platform at /tilray-brands-2024-q1

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time – by inspiring and empowering a worldwide community to live their very best life, enhanced by moments of connection and wellbeing. Tilray’s mission is to be the most responsible, trusted, and market-leading cannabis and consumer products company in the world with a portfolio of innovative, high-quality, and beloved brands that address the needs of the consumers, customers, and patients we serve. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we open a world of well-being, visit and follow @tilray on all social platforms.

For further information:

Media: Berrin Noorata,

Investors: Raphael Gross, (203) 682-8253,



EN
21/09/2023

Underlying

TLRYTilray

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tilray

 PRESS RELEASE
Free
TLRY TILRAY

Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Request...

Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that the Company has submitted an application requesting an extension to regain compliance with Nasdaq’s listing standards regarding its price per share. The Company is evaluating several options including...

August 14, 2025 1 EN
 PRESS RELEASE
Free
TLRY TILRAY

Tilray Medical stringe una partnership strategica in Italia per render...

Tilray Medical stringe una partnership strategica in Italia per rendere più accessibili gli estratti di cannabis terapeutica FL Group, società di Tilray, collabora con Molteni, una grande azienda farmaceutica che si occupa di terapie del dolore e per il trattamento della dipendenza da sostanze NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, una divisione di Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) e leader mondiale nel settore della cannabis terapeutica, impegnata a rafforzare l'alleanza terapeutica tra pazienti e operatori sanitari per consentire decisioni s...

August 13, 2025 1 EN
 PRESS RELEASE
Free
TLRY TILRAY

Tilray Medical Forms Strategic Partnership in Italy to Broaden Access ...

Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts Tilray’s FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, announced today that its wholly-owned subsidiary, FL Group S.R.L., has...

August 13, 2025 1 EN
 PRESS RELEASE
Free
TLRY TILRAY

Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drin...

Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drinks from Fizzy Jane’s and Happy Flower Brands NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- . (“Tilray”) (NASDAQ: TLRY and TSX: TLRY) is building on the momentum of its hemp-derived Delta-9 THC (HDD9) beverage portfolio with new 10mg format extensions from its brands: and . Fizzy Jane’s, the sparkling seltzer line that debuted this spring in Georgia, North Carolina, and South Carolina, is now available in a 10mg HDD9 THC format, enhancing the buzz while keeping the same crisp, fruit-forward refreshment fans love. With 15...

August 12, 2025 1 EN
 PRESS RELEASE
Free
TLRY TILRAY

Tilray Brands Launches The Humble Seed Whole Wheat Protein Crackers at...

Tilray Brands Launches The Humble Seed Whole Wheat Protein Crackers at Whole Foods Market The Humble Seed Introduces the Ultimate Protein Snack and Better-for-You Crackers with 5g of Superseed Protein NEW YORK and WINNIPEG, Manitoba, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Humble Seed, a better-for-you snack brand from Tilray Wellness a subsidiary of Tilray Brands, Inc. (“Tilray”) (NASDAQ: TLRY; TSX: TLRY), today announced the launch of its new featuring 5g of plant-based protein per serving. Available in three crave-worthy flavors—Sea Salt, Garlic Herb, and Rosemary Sea Salt—this innova...

August 7, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch